Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation

European Journal of Clinical Investigation

Volumn 33, Issue 7, 2003, Pages 574-581

  Hutley, L J ^a,c   Newell, F M ^a,c   Joyner, J M ^a,c   Suchting, S J ^a,c   Herington, A C ^b   Cameron, D P ^c   Prins, Johannes B ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Adipose tissue; Human; Linoleic acid; Preadipocyte differentiation; Rosiglitazone

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; INSULIN; LEPTIN; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; FEMALE; FIBROBLAST; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPOGENESIS; MALE; PERITONEAL BIOPSY; PRIORITY JOURNAL; PROADIPOCYTE; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; CELL DIFFERENTIATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LINOLEIC ACID; MALE; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0038804119     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01178.x     Document Type: Article

References (37)

1. Loftus TM, Lane MD. Modulating the transcriptional control of adipogenesis. Curr Opin Genet Dev 1997;7:603-8.
2. Spiegelman BM. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 1998;47:507-14.
3. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S et al. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 1996;271:31771-4.
4. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta-12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-12.
5. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L et al. Activators of peroxisome proliferator-activated Receptor gamma have depot-specific effects on human pre-adipocyte differentiation. J Clin Invest 1997;100:3149-53.
6. Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma. Cell 1998;93:229-40.
7. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995;83:813-9.
8. MacDougald OA, Lane MD. Transcriptional Regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995;64:345-73.
9. Hwang C-S, Loftus TM, Mandrup S, Lane MD. Adipocyte differentiation and leptin expression. Annu Rev Cell Dev Biol 1997;13:231-59.
10. Considine RV, Caro JF. Leptin and the regulation of body weight. Int J Biochem Cell Biol 1997;29 (11): 1255-72.
11. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M et al. Human obese gene expression: Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.
12. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression. Diabetes 1997;46:342-7.
13. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby JE et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998;47: 1384-91.
14. Prins JB, Walker NI, Wintefford CM, Cameron DP. Human adipocyte apoptosis occurs in malignancy. Biochem Biophys Res Comm 1994;205, 1:625-30.
15. Hauner H. Differentiation of Human adipocyte precursor cells under chemically defined culture conditions. In: Oomura Ys, editor. Progress in Obesity Research. London: John Libbey & Company;1990: pp. 213-8.
16. Hutley LJ, Newell FS, Suchting SJ, Prins JB. Adipose tissue. In: Koller MR, Palsson BO, Masters JRWs, editors. Primary Mesenchymal Cells. Dordrecht: Kluwer Academic Publishers;2001:pp. 173-87
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidmium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
19. Ireland RC, Kotarski MA, Johnston LA, Stadler U, Birkenmeier E, Kozak LP. Primary structure of the mouse glycerol-3-phosphate dehydrogenase gene. J Biol Chem 1986;261:11779-85.
20. Masuzaki H, Ogawa Y, Hosoda K, Kawada T, Fushiki T, Nakao K. Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet. Biochem Biophys Res Commun 1995;216:355-8.
21. Stolic M, Russell A, Hutley L, Fielding G, Hay J, MacDonald G et al. Glucose uptake and insulin action in human adipose tissue - influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 2002;26:17-23.
22. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr, 2000;71:179S-88S.
23. Bjorntorp P, Faust IM, Miller WH Jr, Karlsson M, Sypniewska G, Dahlgren K. Dietary and species influence on potential of plasma to stimulate differentiation and lipid accumulation in cultured adipocyte precursors. J Lipid Res 1985;26:1444-54.
24. Sypniewska G, Xu XF, Hager A, Lindahl A, Bjorntorp P. Effects of age, obesity and growth-hormone on adipogenic activity in human plasma. Int J Obes 1987;11:263-73.
25. Olsson U, Bondjers G, Camejo G. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes 1999;48:616-22.
26. King AB. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones. Diabetes Care 2000;23:557.
27. Phillips LS, Grunberger G, Miller E, Patwardhan R, Rappaport EB, Salzman A. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care 2001;24:308-15.
28. Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI. Rosiglitazone monotherapy is effective in patients with type 2 diabetes. J Clin Endocrinol Metab 2001;86:280-8.
29. Dodds PF, Gurr MI, Brindley DN. The glycerol phosphate, dihydroxyacetone phosphate and monoacylglycerol pathways of glycerolipid synthesis in rat adipose-tissue homogenates. Biochem J 1976;160:693-700.
30. Astrup A, Raben A. Obesity: an inherited metabolic deficiency in the control of macronutrient balance? Eur J Clin Nutr 1992;46:611-20.
31. Havel PJ, Townsend R, Chaump L, Teff K. High-fat meals reduce 24-h circulating leptin concentrations in women. Diabetes 1999;48:334-41.
32. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000;59:359-71.
33. Tirosh A, Rudich A, Potashnik R, Bashan N. Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes. Biochem J 2001;355:757-63.
34. Maziere C, Conte MA, Degonvllle J, Ali D, Maziere JC. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 1999;265:116-22.
35. Simopoulos AP. Is insulin resistance influenced by dietary linoleic acid and trans fatty acids? Free Radic Biol Med 1994;17:367-72.
36. Rudich A, Kozlovsky N, Potashnik R, Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 1997;272:E935-40.
37. Tafuri SR. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology 1996;137:4706-12.